Toggle navigation
Home
Search
Services
Blog
Contact
About
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
Wayne State University, Detroit, MI, United States
Search grants from Wayne State University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
Effect of Baclofen on Alcohol Cue-Elicited Urges to Drink and Smoke
Support Services for Three (3) National Information
Diuretic Activity of Adotts in A Double Blind Parallel Study in Man
Buffer and Bandwidth Allocation in ATM Networks
Recently added grants:
New Molecular Probes For Protein Kinases
Molecular characterization of the multi-modal regulation of inositol 1,4,5-trisphosphate receptors
Cell-type? and developmental stage?specific regulation of gene expression in the retina
Molecular Mechanisms Regulating and Interpreting BMP Signaling
International Federation of Placenta Associations
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005022-003
Application #
7329487
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Related projects
NIH 2006
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2004
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2000
N01 CN
Phase II Clinial Trial of New Chemopreventive Agents - W
Kucuk, Omer / Wayne State University
$758,959
Comments
Be the first to comment on this grant